Wikidata

(Q47940160)

English

Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma.

scientific article published in August 2004

In more languages

Statements

title
Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15316501
retrieved
6 February 2018
reference URL
http://europepmc.org/abstract/MED/15316501

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q47940160&oldid=2121436747"